1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Syncom Formulations (India) Limited

Syncom Formulations (India) Limited

SYNCOMF.BO
Syncom Formulations (India) LimitedIN flagBombay Stock Exchange
14.22
INR
+0.23
- -
13.38BMarket Cap

Total Valuation

Syncom Formulations (India) Limited carries a market capitalization of 13.38B, placing it among publicly traded companies globally. Its enterprise value stands at 7.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap13.38B
Enterprise Value7.71B

Share Statistics

Syncom Formulations (India) Limited currently has 940.00M shares outstanding.

Shares Outstanding940.00M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Syncom Formulations (India) Limited trades at a trailing price-to-earnings ratio of 11.54. The price-to-sales ratio is 1.80, and the price-to-book ratio stands at 9.39.

PE Ratio11.54
PS Ratio1.80
PB Ratio9.39
P/TBV Ratio2.13
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Syncom Formulations (India) Limited trades at an EV/EBITDA multiple of 10.88 and an EV/FCF ratio of 883.15. The EV/Sales ratio of 1.58 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.88 provides insight into valuation relative to core operating earnings.

EV / Sales1.58
EV / EBITDA10.88
EV / EBIT10.88
EV / FCF883.15

Financial Position

Syncom Formulations (India) Limited maintains a current ratio of 3.18, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.36, indicating conservative leverage, while an interest coverage ratio of 61.38 demonstrates strong ability to service its debt obligations.

Current Ratio3.18
Quick Ratio1.09
Debt / Equity0.36
Debt / EBITDA0.02
Interest Coverage61.38

Financial Efficiency

Syncom Formulations (India) Limited posts a return on equity of 44.69 and a return on invested capital of 14.04.

Return on Equity (ROE)44.69
Return on Assets (ROA)16.14
Return on Invested Capital (ROIC)14.04
Return on Capital Employed (ROCE)44.41
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover5.46

Taxes

Over the trailing twelve months, Syncom Formulations (India) Limited has paid 246.82M in income taxes, reflecting an effective tax rate of 24.41.

Income Tax246.82M
Effective Tax Rate24.41

Stock Price Statistics

Syncom Formulations (India) Limited's stock has declined approximately -25.15789% over the past 52 weeks. The 50-day moving average sits at 14.30, while the 200-day moving average is 14.33.

Beta (5Y)N/A
52-Week Price Change-25.15789%
50-Day Moving Average14.30
200-Day Moving Average14.33
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Syncom Formulations (India) Limited generated 4.89B in revenue and converted that into 764.38M in net income, yielding earnings per share of 0.89. EBITDA reached 708.98M, while operating income came in at 708.98M.

Revenue4.89B
Gross Profit2.05B
Operating Income708.98M
Pretax Income1.01B
Net Income764.38M
EBITDA708.98M
EBIT708.98M
Earnings Per Share (EPS)0.89

Balance Sheet

Syncom Formulations (India) Limited holds 1.13B in cash and equivalents against 14.74M in total debt, resulting in a net debt position of -36.73M. Total book value stands at 940.00M, with working capital of 2.27B providing operational flexibility.

Cash & Cash Equivalents1.13B
Total Debt14.74M
Net Debt-36.73M
Equity (Book Value)940.00M
Book Value Per Share1.10
Working Capital2.27B

Margins

Syncom Formulations (India) Limited operates with a gross margin of 41.89, reflecting its pricing power and cost economics. The operating margin of 14.49 and net profit margin of 15.63 provide insight into operational efficiency.

Gross Margin41.89
Operating Margin14.49
Pretax Margin20.67
Profit Margin15.63
EBITDA Margin14.49

Stock Splits

Syncom Formulations (India) Limited's most recent stock split took place on August 19, 2013 with a 1:35 split ratio.

Last Split Date8/19/2013
Split Ratio1:35

Scores

Syncom Formulations (India) Limited posts an Altman Z-Score of 6.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score6.32